Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × CTLA-4 Antigen × 1 year × Clear all

Sponsor

Conditions

Melanoma 13 Carcinoma, Renal Cell 10 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Transitional Cell 3 Brain Neoplasms 3 Uveal Melanoma 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Penile Neoplasms 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Histiocytoma, Malignant Fibrous 2 Glioblastoma 2

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡